Reut Rotem1, Ayala Hirsch1, Rachel Michaelson-Cohen2,3, Misgav Rottenstreich1,4, Moshe Barg1, Pnina Mor1,5. 1. Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Hebrew University Faculty of Medicine, POB 3235, 91031, Jerusalem, Israel. 2. Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Hebrew University Faculty of Medicine, POB 3235, 91031, Jerusalem, Israel. rachelmc@szmc.org.il. 3. Medical Genetics Institute, Shaare Zedek Medical Center, Hebrew University Faculty of Medicine, Jerusalem, Israel. rachelmc@szmc.org.il. 4. Department of Nursing, Jerusalem College of Technology, Jerusalem, Israel. 5. Medical Genetics Institute, Shaare Zedek Medical Center, Hebrew University Faculty of Medicine, Jerusalem, Israel.
Abstract
PURPOSE: To evaluate the rates of vaginal birth after cesarean (VBAC) among parturients attempting preterm trial of labor following a cesarean delivery (TOLAC) vs. term TOLAC. METHODS: A multicenter historic cohort study was conducted at two university-affiliated centers between August 2005 and March 2021. Parturients in their second delivery, attempting TOLAC after a single low segment transverse cesarean delivery were included. We retrospectively examined computerized medical records of all preterm (< 37 weeks) and term (37-42 weeks) births. Multifetal gestations and postterm deliveries (≥ 42 weeks) were excluded. A univariate analysis was conducted, followed by a multivariate analysis. RESULTS: 4865 second deliveries following previous cesarean were identified: 212 (4.4%) preterm and 4653 (95.6%) term. Hypertensive disorders, diabetes and fertility treatments were significantly more prevalent in the preterm group. VBAC rate was significantly lower in preterm group (57.5 vs 79.7%., p < 0.01), including both spontaneous and vaginal-assisted deliveries. In multivariate analysis, preterm TOLAC was independently associated with TOLAC failure [adjusted odds ratio 2.24, [95% confidence interval 1.62-3.09]. Overall, maternal outcomes were favorable. Rates of uterine rupture, re-laparotomy and postpartum hemorrhage were comparable between groups. Neonatal outcomes were less favorable among the preterm group; however, preterm vs. term TOLAC was not associated with low 5 min Apgar score (aOR 1.76, 95% CI 0.92-3.40). CONCLUSION: In our study, VBAC rates were lower in preterm compared to term deliveries. Maternal outcomes were comparable. Neonatal outcomes were less favorable in the preterm group, more likely due to prematurity than delivery mode.
PURPOSE: To evaluate the rates of vaginal birth after cesarean (VBAC) among parturients attempting preterm trial of labor following a cesarean delivery (TOLAC) vs. term TOLAC. METHODS: A multicenter historic cohort study was conducted at two university-affiliated centers between August 2005 and March 2021. Parturients in their second delivery, attempting TOLAC after a single low segment transverse cesarean delivery were included. We retrospectively examined computerized medical records of all preterm (< 37 weeks) and term (37-42 weeks) births. Multifetal gestations and postterm deliveries (≥ 42 weeks) were excluded. A univariate analysis was conducted, followed by a multivariate analysis. RESULTS: 4865 second deliveries following previous cesarean were identified: 212 (4.4%) preterm and 4653 (95.6%) term. Hypertensive disorders, diabetes and fertility treatments were significantly more prevalent in the preterm group. VBAC rate was significantly lower in preterm group (57.5 vs 79.7%., p < 0.01), including both spontaneous and vaginal-assisted deliveries. In multivariate analysis, preterm TOLAC was independently associated with TOLAC failure [adjusted odds ratio 2.24, [95% confidence interval 1.62-3.09]. Overall, maternal outcomes were favorable. Rates of uterine rupture, re-laparotomy and postpartum hemorrhage were comparable between groups. Neonatal outcomes were less favorable among the preterm group; however, preterm vs. term TOLAC was not associated with low 5 min Apgar score (aOR 1.76, 95% CI 0.92-3.40). CONCLUSION: In our study, VBAC rates were lower in preterm compared to term deliveries. Maternal outcomes were comparable. Neonatal outcomes were less favorable in the preterm group, more likely due to prematurity than delivery mode.
Authors: Celeste P Durnwald; Dwight J Rouse; Kenneth J Leveno; Catherine Y Spong; Cora MacPherson; Michael W Varner; Atef H Moawad; Steve N Caritis; Margaret Harper; Ronald J Wapner; Yoram Sorokin; Menachem Miodovnik; Marshall Carpenter; Alan M Peaceman; Mary Jo O'Sullivan; Baha Sibai; Oded Langer; John M Thorp; Susan M Ramin; Brian M Mercer; Steven G Gabbe Journal: Am J Obstet Gynecol Date: 2006-10 Impact factor: 8.661
Authors: Gerard H A Visser; Diogo Ayres-de-Campos; Eytan R Barnea; Luc de Bernis; Gian Carlo Di Renzo; Maria Fernanda Escobar Vidarte; Isabel Lloyd; Anwar H Nassar; Wanda Nicholson; P K Shah; William Stones; Luming Sun; Gerhard B Theron; Salimah Walani Journal: Lancet Date: 2018-10-13 Impact factor: 79.321
Authors: William A Grobman; Yinglei Lai; Mark B Landon; Catherine Y Spong; Kenneth J Leveno; Dwight J Rouse; Michael W Varner; Atef H Moawad; Steve N Caritis; Margaret Harper; Ronald J Wapner; Yoram Sorokin; Menachem Miodovnik; Marshall Carpenter; Mary J O'Sullivan; Baha M Sibai; Oded Langer; John M Thorp; Susan M Ramin; Brian M Mercer Journal: Obstet Gynecol Date: 2007-04 Impact factor: 7.661
Authors: Ana Pilar Betrán; Marleen Temmerman; Carol Kingdon; Abdu Mohiddin; Newton Opiyo; Maria Regina Torloni; Jun Zhang; Othiniel Musana; Sikolia Z Wanyonyi; Ahmet Metin Gülmezoglu; Soo Downe Journal: Lancet Date: 2018-10-13 Impact factor: 79.321